BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 10585443)

  • 1. Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin.
    Nellist M; van Slegtenhorst MA; Goedbloed M; van den Ouweland AM; Halley DJ; van der Sluijs P
    J Biol Chem; 1999 Dec; 274(50):35647-52. PubMed ID: 10585443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex.
    Nellist M; Verhaaf B; Goedbloed MA; Reuser AJ; van den Ouweland AM; Halley DJ
    Hum Mol Genet; 2001 Dec; 10(25):2889-98. PubMed ID: 11741832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products.
    van Slegtenhorst M; Nellist M; Nagelkerken B; Cheadle J; Snell R; van den Ouweland A; Reuser A; Sampson J; Halley D; van der Sluijs P
    Hum Mol Genet; 1998 Jun; 7(6):1053-7. PubMed ID: 9580671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis.
    Aicher LD; Campbell JS; Yeung RS
    J Biol Chem; 2001 Jun; 276(24):21017-21. PubMed ID: 11290735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin.
    Hodges AK; Li S; Maynard J; Parry L; Braverman R; Cheadle JP; DeClue JE; Sampson JR
    Hum Mol Genet; 2001 Dec; 10(25):2899-905. PubMed ID: 11741833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tuberin-hamartin complex negatively regulates beta-catenin signaling activity.
    Mak BC; Takemaru K; Kenerson HL; Moon RT; Yeung RS
    J Biol Chem; 2003 Feb; 278(8):5947-51. PubMed ID: 12511557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation.
    Miloloza A; Kubista M; Rosner M; Hengstschläger M
    J Neuropathol Exp Neurol; 2002 Feb; 61(2):154-63. PubMed ID: 11853018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.
    Tee AR; Manning BD; Roux PP; Cantley LC; Blenis J
    Curr Biol; 2003 Aug; 13(15):1259-68. PubMed ID: 12906785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of tuberous sclerosis complex (TSC) function by 14-3-3 proteins.
    Nellist M; Goedbloed MA; Halley DJ
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):587-91. PubMed ID: 12773161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicompartmental distribution of the tuberous sclerosis gene products, hamartin and tuberin.
    Yamamoto Y; Jones KA; Mak BC; Muehlenbachs A; Yeung RS
    Arch Biochem Biophys; 2002 Aug; 404(2):210-7. PubMed ID: 12147258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of the interaction between tuberin and 14-3-3zeta.
    Nellist M; Goedbloed MA; de Winter C; Verhaaf B; Jankie A; Reuser AJ; van den Ouweland AM; van der Sluijs P; Halley DJ
    J Biol Chem; 2002 Oct; 277(42):39417-24. PubMed ID: 12176984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle-regulated phosphorylation of hamartin, the product of the tuberous sclerosis complex 1 gene, by cyclin-dependent kinase 1/cyclin B.
    Astrinidis A; Senapedis W; Coleman TR; Henske EP
    J Biol Chem; 2003 Dec; 278(51):51372-9. PubMed ID: 14551205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromas.
    Fackler I; DeClue JE; Rust H; Vu PA; Kutzner H; Rütten A; Kaddu S; Sander CA; Volkenandt M; Johnson MW; Vinters HV; Wienecke R
    J Cutan Pathol; 2003 Mar; 30(3):174-7. PubMed ID: 12641776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination.
    Benvenuto G; Li S; Brown SJ; Braverman R; Vass WC; Cheadle JP; Halley DJ; Sampson JR; Wienecke R; DeClue JE
    Oncogene; 2000 Dec; 19(54):6306-16. PubMed ID: 11175345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas.
    Plank TL; Logginidou H; Klein-Szanto A; Henske EP
    Mod Pathol; 1999 May; 12(5):539-45. PubMed ID: 10349994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pam and its ortholog highwire interact with and may negatively regulate the TSC1.TSC2 complex.
    Murthy V; Han S; Beauchamp RL; Smith N; Haddad LA; Ito N; Ramesh V
    J Biol Chem; 2004 Jan; 279(2):1351-8. PubMed ID: 14559897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental expression of the tuberous sclerosis proteins tuberin and hamartin.
    Murthy V; Stemmer-Rachamimov AO; Haddad LA; Roy JE; Cutone AN; Beauchamp RL; Smith N; Louis DN; Ramesh V
    Acta Neuropathol; 2001 Mar; 101(3):202-10. PubMed ID: 11307618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling.
    Tee AR; Fingar DC; Manning BD; Kwiatkowski DJ; Cantley LC; Blenis J
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13571-6. PubMed ID: 12271141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes.
    Jiang WG; Sampson J; Martin TA; Lee-Jones L; Watkins G; Douglas-Jones A; Mokbel K; Mansel RE
    Eur J Cancer; 2005 Jul; 41(11):1628-36. PubMed ID: 15951164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberous sclerosis: immunohistochemistry expression of tuberin and hamartin in a 31-week gestational fetus.
    Vinaitheerthan M; Wei J; Mizuguchi M; Greco A; Barness EG
    Fetal Pediatr Pathol; 2004; 23(4):241-9. PubMed ID: 16095035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.